We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ANDRX, GENPHARM SIGN DEAL TO LAUNCH GENERIC PAXIL
ANDRX, GENPHARM SIGN DEAL TO LAUNCH GENERIC PAXIL
May 18, 2004
Andrx announced May 12 that it had entered into an agreement with Genpharm to obtain the firm’s exclusive U.S. marketing rights for a generic version of GlaxoSmithKline’s (GSK’s) antidepressant Paxil (paroxetine) in the 10-, 20-, 30- and 40-mg strength tablets.